Research Article
In Silico Design of BACE1 Inhibitor for Alzheimer’s Disease by Traditional Chinese Medicine
Table 1
Top ten candidates and control.
| Name | -PLP1 | -PLP2 | -PMF | BBB Level | CYP2D6 | Hepatotoxicity |
| Diterpenoid EF-D | 79.04 | 75.67 | 195.32 | 4 | 0 | 0 | Triptofordin B1 | 68.44 | 62.28 | 194.61 | 2 | 0 | 0 | Shionoside C | 71.67 | 69.36 | 193.84 | 4 | 0 | 0 | Jangomolide | 72.27 | 67.01 | 187.36 | 3 | 0 | 0 | Vibsanin W | 77.98 | 76.62 | 184.31 | 4 | 0 | 0 | 2α,6α-Dihydroxybetulinic acid | 59.52 | 57.72 | 183.93 | 2 | 0 | 0 | Benzoylramanone | 63.59 | 61.05 | 183.67 | 2 | 0 | 0 | Pseurata D | 63.28 | 62.87 | 180.42 | 4 | 0 | 0 | Vibsanin I | 78.18 | 72.43 | 179.15 | 4 | 0 | 0 | 1M7 | 70.70 | 52.10 | 119.39 | 3 | 0 | 1 |
|
|
Control. BBB level (blood brain barrier): high penetration = 1; medium penetration = 2; low penetration = 3; undefined penetration = 4. CYP2D6: noninhibitor = 0; Inhibitor = 1. Hepatotoxicity: Non-inhibitor = 0; inhibitor = 1.
|